Speaker illustration

Doctor Paul Welsh

Cardiovascular Research Centre of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

After completing a BSc (Hons) in Immunology, Dr Welsh completed his PhD on Inflammatory markers of Cardiovascular disease at Glasgow Royal Infirmary in 2008, and completed an MSc in Epidemiology at London School of Hygiene and Tropical Medicine with distinction, winning the 150th Anniversary prize. He has held two British Heart Foundation Research Fellowships . He is an associate editor of Atherosclerosis, and a member of the Independent Scientific Advisory Committee (ISAC) for CPRD data. Dr Welsh's interests encompass biomarkers, genetic, and clinical research in the fields of cardiovascular disease, diabetes, and healthy ageing, including data from clinical trials (including DiRECT, WOSCOPS, PROSPER, ASCOT, and ADVANCE), large observational studies (UK Biobank, Generation Scotland, British Regional Heart Study and MIDSPAN,) and meta-analyses. He has a particular interest in CVD risk stratification, and cardiac biomarkers. He has authored more than 150 publications.

The burden of coronary revascularization associated with lipoprotein(a) in patients with atherosclerotic cardiovascular disease: data from the UK Biobank

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Pericardial disease, myocardial disease, COVID-19

Thumbnail

Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology

Session: Risk Factors and Prevention ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk